Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Travera Inc
Eastern Cooperative Oncology Group
Global BioClinical
University of California, Irvine
University of Maryland, Baltimore
University of Southern California
Masonic Cancer Center, University of Minnesota
SWOG Cancer Research Network
Alliance for Clinical Trials in Oncology